{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:17:42Z","timestamp":1787872662184,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-025-00517-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:15:55Z","timestamp":1767777355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of male sex in clinical and laboratory features of systemic sclerosis"],"prefix":"10.1186","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0516-6918","authenticated-orcid":false,"given":"Ana Paula","family":"Luppino-Assad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Vidaurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Camata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Miossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Bruscato","family":"Bortoluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ferreira","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Medeiros-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percival D.","family":"Sampaio-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"517_CR1","doi-asserted-by":"publisher","unstructured":"Denton CP, Khanna D, Systemic. sclerosis. Lancet 2017;390:1685\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","DOI":"10.1016\/S0140-6736(17)30933-9"},{"issue":"7","key":"517_CR2","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","volume":"60","author":"M Bairkdar","year":"2021","unstructured":"Bairkdar M, Rossides M, Westerlind H, Hesselstrand R, Arkema EV, Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(7):3121\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/keab190.","journal-title":"Rheumatology (Oxford)"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"517_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41584-022-00803-6","volume":"18","author":"R Lafyatis","year":"2022","unstructured":"Lafyatis R, Valenzi E. Assessment of disease outcome measures in systemic sclerosis. Nat Rev Rheumatol. 2022;18(9):527\u201341. https:\/\/doi.org\/10.1038\/s41584-022-00803-6.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"517_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5301\/jsrd.5000256","volume":"2","author":"SM Proudman","year":"2017","unstructured":"Proudman SM, Huq M, Stevens W, et al. What have multicentre registries across the world taught Us about the disease features of systemic sclerosis? J Scleroderma Relat Disord. 2017;2(3):169\u201382. https:\/\/doi.org\/10.5301\/jsrd.5000256.","journal-title":"J Scleroderma Relat Disord"},{"key":"517_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12016-013-8392-9","volume":"47","author":"F D\u2019Amico","year":"2014","unstructured":"D\u2019Amico F, Skarmoutsou E, Mazzarino MC. The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. Clin Rev Allergy Immunol. 2014;47:334\u201343.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"517_CR7","doi-asserted-by":"publisher","first-page":"102494","DOI":"10.1016\/j.autrev.2020.102494","volume":"19","author":"M Hughes","year":"2020","unstructured":"Hughes M, Pauling JD, Armstrong-James L, Denton CP, Galdas P, Flurey C. Gender-related differences in systemic sclerosis. Autoimmun Rev. 2020;19(4):102494. https:\/\/doi.org\/10.1016\/j.autrev.2020.102494.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"517_CR8","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/rheumatology\/keac660","volume":"62","author":"C Campochiaro","year":"2023","unstructured":"Campochiaro C, Hoffmann-Vold AM, Avouac J, Henes J, de Vries-Bouwstra J, Smith V, et al. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis. Rheumatology (Oxford). 2023;62(7):2483\u201391. https:\/\/doi.org\/10.1093\/rheumatology\/keac660.","journal-title":"Rheumatology (Oxford)"},{"key":"517_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/rheumatology\/35.9.910","volume":"35","author":"CP Sime\u00f3n","year":"1996","unstructured":"Sime\u00f3n CP, Castro-Guardiola A, Fonollosa V, et al. Systemic sclerosis in men: clinical and immunological differences. Br J Rheumatol. 1996;35:910\u20131.","journal-title":"Br J Rheumatol"},{"issue":"Suppl 106","key":"517_CR10","first-page":"89","volume":"35","author":"M Freire","year":"2017","unstructured":"Freire M, Rivera A, Sope\u00f1a B, Tolosa Vilella C, Guill\u00e9n-Del Castillo A, Colunga Arg\u00fcelles D, RESCLE investigators, Autoimmune Diseases Study Group (GEAS), et al. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review. Clin Exp Rheumatol. 2017;35(Suppl 106):89\u201397.","journal-title":"Clin Exp Rheumatol"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.revmed.2007.07.010","volume":"29","author":"JB Gaultier","year":"2008","unstructured":"Gaultier JB, Hot A, Cath\u00e9bras P, Grange C, Ninet J, Rousset H. Systemic sclerosis in men]. [Article in French]. Rev Med Interne. 2008;29:181\u20136.","journal-title":"Rev Med Interne"},{"key":"517_CR12","doi-asserted-by":"publisher","first-page":"e17551","DOI":"10.1371\/journal.pone.0017551","volume":"6","author":"C Nguyen","year":"2011","unstructured":"Nguyen C, B\u00e9rezn\u00e9 A, Baubet T, et al. Groupe Fran\u00e7ais de recherche Sur La Scl\u00e9rodermie. Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis. PLoS ONE. 2011;6:e17551.","journal-title":"PLoS ONE"},{"key":"517_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/art.24284","volume":"61","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs B, Baron M, Canadian Scleroderma Research Group. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum. 2009;61:274\u20138.","journal-title":"Arthritis Rheum"},{"key":"517_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum. 2010;39:269\u201377.","journal-title":"Semin Arthritis Rheum"},{"key":"517_CR15","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3899\/jrheum.140006","volume":"41","author":"H Hussein","year":"2014","unstructured":"Hussein H, Lee P, Chau C, Johnson SR. The effect of male sex on survival in systemic sclerosis. J Rheumatol. 2014;41:2193\u2013200.","journal-title":"J Rheumatol"},{"issue":"Suppl 86","key":"517_CR16","first-page":"S10","volume":"32","author":"VC Delisle","year":"2014","unstructured":"Delisle VC, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry. Clin Exp Rheumatol. 2014;32(Suppl 86):S10\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"517_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/jrheum.120667","volume":"40","author":"ST Panopoulos","year":"2013","unstructured":"Panopoulos ST, Bournia VK, Sfikakis PP. Is vasculopathy associated with systemic sclerosis more severe in men? J Rheumatol. 2013;40:46\u201351.","journal-title":"J Rheumatol"},{"key":"517_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","volume":"75","author":"M Elhai","year":"2016","unstructured":"Elhai M, Avouac J, Walker UA, et al. EUSTAR co-authors. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016;75:163\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 113","key":"517_CR19","first-page":"S68","volume":"36","author":"PE Carreira","year":"2018","unstructured":"Carreira PE, Carmona L, Joven BE, et al. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018;36(Suppl 113):S68\u201375.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"517_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.5301\/jsrd.5000209","volume":"1","author":"C Peoples","year":"2016","unstructured":"Peoples C, Medsger TA Jr, Lucas M, Rosario BL, Feghali-Bostwick CA. Gender differences in systemic sclerosis: relationship to clinical features, serological status and outcomes. J Scleroderma Relat Disord. 2016;1(2):204\u201312.","journal-title":"J Scleroderma Relat Disord"},{"issue":"Suppl 25","key":"517_CR21","first-page":"40","volume":"38","author":"C Ferri","year":"2020","unstructured":"Ferri C, Giuggioli D, Guiducci S, the Italian Society for Rheumatology (SIR). Systemic sclerosis progression investigation (SPRING) Italian registry: demographic and clinic-serological features of scleroderma spectrum. Clin Exp Rheumatol. 2020;38(Suppl 25):40\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"517_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3899\/jrheum.210794","volume":"49","author":"R De Angelis","year":"2022","unstructured":"De Angelis R, Giuggioli D, Bajocchi G, et al. Sex-related differences in systemic sclerosis: a multicenter cross-sectional study from the National registry of the Italian society for rheumatology. J Rheumatol. 2022;49:176\u201385.","journal-title":"J Rheumatol"},{"issue":"6","key":"517_CR23","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/ard.2008.091348","volume":"68","author":"UA Walker","year":"2009","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, et al. EUSTAR co-authors. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research (EUSTAR) group database. Ann Rheum Dis. 2009;68(6):856\u201362. https:\/\/doi.org\/10.1136\/ard.2008.091348.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"517_CR24","doi-asserted-by":"publisher","first-page":"103159","DOI":"10.1016\/j.autrev.2022.103159","volume":"21","author":"C Ferri","year":"2022","unstructured":"Ferri C, De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, et al. SPRING-SIR (Systemic sclerosis progression investigation group of the Italian society of Rheumatology). Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. Autoimmun Rev. 2022;21(10):103159. https:\/\/doi.org\/10.1016\/j.autrev.2022.103159.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"517_CR25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/art.39613","volume":"68","author":"A Meyer","year":"2016","unstructured":"Meyer A, Chifflot H, Chatelus E, Kleinmann JF, Ronde-Ousteau C, Klein D, et al. Spatial heterogeneity of systemic sclerosis in france: high prevalence in the Northeast region. Arthritis Rheumatol. 2016;68(7):1731\u20137. https:\/\/doi.org\/10.1002\/art.39613.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"517_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3899\/jrheum.180042","volume":"46","author":"H Al-Sheikh","year":"2019","unstructured":"Al-Sheikh H, Ahmad Z, Johnson SR. Ethnic variations in systemic sclerosis disease Manifestations, internal organ Involvement, and mortality. J Rheumatol. 2019;46(9):1103\u20138. https:\/\/doi.org\/10.3899\/jrheum.180042.","journal-title":"J Rheumatol"},{"issue":"4","key":"517_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3899\/jrheum.080915","volume":"36","author":"AH Low","year":"2009","unstructured":"Low AH, Johnson SR, Lee P. Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis. J Rheumatol. 2009;36(4):787\u201393. https:\/\/doi.org\/10.3899\/jrheum.080915.","journal-title":"J Rheumatol"},{"issue":"8","key":"517_CR28","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48(8):2246\u201355. https:\/\/doi.org\/10.1002\/art.11073.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"517_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","volume":"37","author":"I Marie","year":"2015","unstructured":"Marie I, Gehanno JF. Environmental risk factors of systemic sclerosis. Semin Immunopathol. 2015;37(5):463\u201373. https:\/\/doi.org\/10.1007\/s00281-015-0507-3.","journal-title":"Semin Immunopathol"},{"key":"517_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10067-016-3533-1","volume":"36","author":"M Rubio-Rivas","year":"2017","unstructured":"Rubio-Rivas M, Moreno R, Corbella X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol. 2017;36:569\u201382. https:\/\/doi.org\/10.1007\/s10067-016-3533-1.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"517_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/rheumatology\/ket163","volume":"52","author":"RG Marangoni","year":"2013","unstructured":"Marangoni RG, Rocha LF, Del Rio AP, Yoshinari NH, Marques-Neto JF, Sampaio-Barros PD. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort. Rheumatology (Oxford). 2013;52(8):1520\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"517_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00296-015-3412-0","volume":"36","author":"LF Rocha","year":"2016","unstructured":"Rocha LF, Luppino Assad AP, Marangoni RG, Del Rio AP, Marques-Neto JF, Sampaio-Barros PD. Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort. Rheumatol Int. 2016;36(5):697\u2013702.","journal-title":"Rheumatol Int"},{"key":"517_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10067-019-04575-5","volume":"39","author":"C Mendes","year":"2020","unstructured":"Mendes C, Viana VS, Pasoto SG, Leon EP, Bonfa E, Sampaio-Barros PD. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis. Clin Rheumatol. 2020;39:9\u201317. https:\/\/doi.org\/10.1007\/s10067-019-04575-5.","journal-title":"Clin Rheumatol"},{"key":"517_CR34","doi-asserted-by":"publisher","unstructured":"Aguila LA, da Silva HC, Medeiros-Ribeiro AC, Bunjes BG, Luppino-Assad AP, Sampaio-Barros PD. Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis. Rheumatol Int. 2021;41(6):1143\u20131150. https:\/\/doi.org\/10.1007\/s00296-020-04693-3. PMID: 32862308.","DOI":"10.1007\/s00296-020-04693-3"},{"issue":"5","key":"517_CR35","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00296-015-3412-0","volume":"36","author":"LF Rocha","year":"2016","unstructured":"Rocha LF, Luppino Assad AP, Marangoni RG, Del Rio AP, Marques-Neto JF, Sampaio-Barros PD. Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort. Rheumatol Int. 2016;36(5):697\u2013702. https:\/\/doi.org\/10.1007\/s00296-015-3412-0.","journal-title":"Rheumatol Int"},{"issue":"7","key":"517_CR36","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/rheumatology\/kez486","volume":"59","author":"VK Jaeger","year":"2020","unstructured":"Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Air\u00f2 P, et al. EUSTAR co-authors. Racial differences in systemic sclerosis disease presentation: a European scleroderma trials and research group study. Rheumatology (Oxford). 2020;59(7):1684\u201394. https:\/\/doi.org\/10.1093\/rheumatology\/kez486.","journal-title":"Rheumatology (Oxford)"},{"key":"517_CR37","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"517_CR38","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell NWF. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"key":"517_CR39","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, ESC Scientific Document Group. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67\u2013119.","DOI":"10.1093\/eurheartj\/ehv317"},{"issue":"4","key":"517_CR40","doi-asserted-by":"publisher","first-page":"2401325","DOI":"10.1183\/13993003.01325-2024","volume":"64","author":"KM Chin","year":"2024","unstructured":"Chin KM, Gaine SP, Gerges C, Jing ZC, Mathai SC, Tamura Y, et al. Treatment algorithm for pulmonary arterial hypertension. Eur Respir J. 2024;64(4):2401325. https:\/\/doi.org\/10.1183\/13993003.01325-2024.","journal-title":"Eur Respir J"},{"key":"517_CR41","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","volume":"30","author":"M Krzyscczak","year":"2011","unstructured":"Krzyscczak M, Li Y, Ross SJ, Ceribelli A, Chan EKL, Bubb MR, et al. Gender and ethnicity differences in the prevalence of scleroderma-related antibodies. Clin Rheumatol. 2011;30:1333\u20139.","journal-title":"Clin Rheumatol"},{"key":"517_CR42","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/art.34482","volume":"64","author":"V Steen","year":"2012","unstructured":"Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr. A clinical and serologic comparison of African-American and Caucasian patients with systemic sclerosis. Arthritis Rheum. 2012;64:2986\u201394.","journal-title":"Arthritis Rheum"},{"key":"517_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","volume":"92","author":"AC Gelber","year":"2013","unstructured":"Gelber AC, Manno RL, Shah AA, Woods A, Le EN, Boin F, et al. Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins scleroderma center and review of the literature. Med (Baltim). 2013;92:191\u2013205.","journal-title":"Med (Baltim)"},{"key":"517_CR44","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1053\/sarh.2001.20268","volume":"30","author":"JD Reveille","year":"2001","unstructured":"Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and Immunogenetic determinants. Semin Arthritis Rheum. 2001;30:332\u201346.","journal-title":"Semin Arthritis Rheum"},{"issue":"161","key":"517_CR45","doi-asserted-by":"publisher","first-page":"210053","DOI":"10.1183\/16000617.0053-2021","volume":"30","author":"A Haque","year":"2021","unstructured":"Haque A, Kiely DG, Kovacs G, Thompson AAR, Condliffe R. Pulmonary hypertension phenotypes in patients with systemic sclerosis. Eur Respir Rev. 2021;30(161):210053. https:\/\/doi.org\/10.1183\/16000617.0053-2021.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"517_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ard.2008.103382","volume":"69","author":"Y Allanore","year":"2010","unstructured":"Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR scleroderma trial and research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010;69(1):218\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"517_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/23971983231163413","volume":"8","author":"C Bruni","year":"2023","unstructured":"Bruni C, Buch MH, Djokovic A, De Luca G, Dumitru RB, Giollo A, et al. Consensus on the assessment of systemic sclerosis-associated primary heart involvement: world scleroderma Foundation\/Heart failure association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord. 2023;8(3):169\u201382. PMID: 37744047; PMCID: PMC10515996.","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"517_CR48","doi-asserted-by":"publisher","first-page":"00235","DOI":"10.1183\/23120541.00235-2020","volume":"7","author":"AM Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O. Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Res. 2021;7(1):00235\u20132020. https:\/\/doi.org\/10.1183\/23120541.00235-2020.","journal-title":"ERJ Open Res"},{"key":"517_CR49","unstructured":"IBGE. (2010) Censo Demogr\u00e1fico 2010. Caracter\u00edsticas Da Popula\u00e7\u00e3o e Dos Domic\u00edlios. Inst Bras Geografia Estat\u00edstica 48."},{"issue":"9","key":"517_CR50","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.38029","volume":"65","author":"G Lef\u00e8vre","year":"2013","unstructured":"Lef\u00e8vre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and prognostic factors in systemic sclerosis\u2013associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013;65(9):2412\u201323.","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00517-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00517-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00517-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:58:33Z","timestamp":1770202713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42358-025-00517-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00517-9","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}